Download Testing Algorithm for the Screening and Diagnosis of Hepatitis C

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Common cold wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Infection wikipedia , lookup

Antibody wikipedia , lookup

Neonatal infection wikipedia , lookup

Monoclonal antibody wikipedia , lookup

Infection control wikipedia , lookup

Childhood immunizations in the United States wikipedia , lookup

Hepatitis wikipedia , lookup

West Nile fever wikipedia , lookup

Marburg virus disease wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Henipavirus wikipedia , lookup

ELISA wikipedia , lookup

Hepatitis B wikipedia , lookup

Hepatitis C wikipedia , lookup

Transcript
Testing Algorithm for the Screening and Diagnosis of Hepatitis C
Clear serum specimen
Hemolyzed or cadaveric serum specimen
Screening in the following patient type:
■ Recipient of blood or blood products
prior to 1992
■ Injection drug user
■ All persons born from 1945 through 1965*
Diagnostic testing: Patient
with abnormal liver enzymes
with or without symptoms
HCSCR / Hepatitis C Antibody Screen
with Reflex to HCV RNA by PCR, Serum
Reactive antibody screen automatically
reflexes to PCR assay
HCPCR / Hepatitis C Antibody with
Reflex to HCV RNA by PCR, Serum
Reactive antibody result automatically
reflexes to PCR assay
Type of Patient
■ Acute hepatitis
■ Immunocompromised
HCVQU / Hepatitis C Virus (HCV) RNA
Detection and Quantification by Real-Time
Reverse Transcription-PCR (RT-PCR), Serum
Reactive antibody screen automatically
reflexes to PCR assay
Screening in the following patient type:
■ Recipient of blood or blood products
prior to 1992
■ Injection drug user
■ All persons born from 1945 through 1965*
HCCAD / Hepatitis C Virus
Antibody Screen for Cadaveric or
Hemolyzed Specimens, Serum
Diagnostic testing: Patient
with abnormal liver enzymes
with or without symptoms
HCCDD / Hepatitis C Virus
Antibody in Cadaveric or
Hemolyzed Specimens, Serum
Antibody result
ReaCtive
Automatic reflex to:
Hepatitis C Virus (HCV) RNA Detection
and Quantification by Real Time Reverse
Transcription PCR (RT-PCR), Serum
Repeat HCVQU
in 1 to 2 months if
abnormal liver enzyme
levels persist without
alternative diagnosis
Negative
Any viral load
Request HCVQU in 1 to 2
months if abnormal liver
enzyme levels persist without
alternative diagnosis
Active HCV infection
follow-up and treatment
decisions depend on
patient risk group
ReaCtive
Automatic reflex to:
HCVL / Hepatitis C Virus
Antibody Confirmation, Serum
Positive
Negative
Optional:
HCVL / Hepatitis C Virus
Antibody Confirmation, Serum
Negative
False-reactive HCV
antibody screen result
Active HCV infection
Go to HCV Treatment Algorithm
Past/resolved
HCV infection
No evidence of prior
exposure to HCV
Any viral load
Active or past/resolved
HCV infection
Positive
Negative
Negative
Submit a nonhemolyzed (ie clear) serum specimen for
HCVQU / Hepatitis C Virus (HCV) RNA Detection and
Quantification by Real-Time Reverse Transcription-PCR
(RT-PCR), Serum to distinguish between active and
past/resolved HCV infection
False-reactive HCV
antibody result
* Centers for Disease Control and Prevention. Recommendations for the identification of chronic
hepatitis C virus infection among persons born during 1945-1965. MMWR 2012;61(RR-4):1-32
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.
MAYO, Mayo Medical Laboratories and the triple-shield Mayo logo are trademarks and/or service marks of MFMER.
03/2015